Hammad Jeilani

Hammad Jeilani is an accomplished professional with a diverse educational background and a range of experiences in the healthcare, innovation, and academic sectors. He holds a Bachelor of Medicine, Bachelor of Surgery (MBBS) in Medicine from various prestigious institutions including Barts and the London School of Medicine and Dentistry, Queen Mary University of London, and studied at Dulwich College. Hammad also pursued an MSc in Health and International Development from The London School of Economics and Political Science (LSE).

In terms of his professional endeavors, Hammad Jeilani is currently serving as the Director and Co-Founder of Apian, a role indicative of his entrepreneurial spirit and leadership capabilities. Prior to this, he held the position of Innovation Fellow at Mid and South Essex NHS Foundation Trust, showcasing his commitment to driving innovation in healthcare. He has also been involved in various capacities within the NHS, having worked as an NHS Clinical Entrepreneur at NHS England and NHS Improvement.

Hammad's career trajectory also includes roles beyond the healthcare sector, such as serving as a First Aid Responder at Wembley National Stadium Ltd, and gaining experience as a Private Academic Tutor, emphasizing his versatile skill set and adaptability. Furthermore, his past engagements highlight his academic and research contributions, having been associated with esteemed organizations like the Royal College of Pathologists (RCPath), Satellite Applications Catapult, UK Space Agency, European Space Agency (ESA), among others.

Throughout his professional journey, Hammad Jeilani has demonstrated a keen interest in space science and healthcare innovation, as evidenced by his involvement in initiatives such as the UK Space Agency's SatelLife Competition and insights gained from organizations like the European Space Agency. His research experience at institutions like Barts Cancer Institute, London School of Hygiene and Tropical Medicine, and The Royal London Hospital reflects his dedication to advancing the fields of oncology, public health, and trauma care.